SWTX | | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Apr 27, 2021 | Sale | $75.05 | 201 | 15,085 | 144,959 | Apr 28, 2021, 08:18 PM |
SWTX | | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Apr 28, 2021 | Sale | $76.20 | 19,231 | 1,465,437 | 125,728 | Apr 28, 2021, 08:18 PM |
SWTX | | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Apr 14, 2021 | Sale | $75.08 | 511 | 38,365 | 146,217 | Apr 19, 2021, 06:07 AM |
SWTX | | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Apr 15, 2021 | Sale | $75.01 | 1,057 | 79,291 | 145,160 | Apr 19, 2021, 06:07 AM |
SWTX | | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Sep 17, 2019 | Buy | $18.00 | 275,000 | 4,950,000 | 7,406,307 | Sep 19, 2019, 07:12 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 27, 2014 | Sale | $127.63 | 11,460 | 1,462,671 | 112,418 | Oct 28, 2014, 05:41 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 03, 2014 | Sale | $107.53 | 20,050 | 2,156,040 | 116,893 | Oct 07, 2014, 08:13 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Sep 24, 2014 | Sale | $159.50 | 76 | 12,122 | 106,868 | Sep 26, 2014, 05:53 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Aug 04, 2014 | Sale | $157.42 | 1,662 | 261,632 | 106,944 | Aug 05, 2014, 04:55 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 06, 2014 | Option Exercise | $124.47 | 7,600 | 945,972 | 98,618 | Feb 10, 2014, 06:47 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 07, 2014 | Sale | $155.57 | 1,620 | 252,030 | 102,963 | Feb 10, 2014, 06:47 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 10, 2014 | Sale | $167.31 | 1,635 | 273,552 | 101,308 | Feb 10, 2014, 06:47 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 03, 2014 | Sale | $157.14 | 852 | 133,883 | 102,216 | Feb 05, 2014, 07:58 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 04, 2014 | Option Exercise | $111.91 | 64,876 | 7,260,250 | 124,455 | Feb 05, 2014, 07:58 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Jan 29, 2014 | Sale | $133.31 | 1,118 | 149,039 | 103,086 | Jan 31, 2014, 05:30 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Nov 04, 2013 | Sale | $77.76 | 28,250 | 2,196,626 | 118,311 | Nov 05, 2013, 06:50 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 28, 2013 | Sale | $102.89 | 80,074 | 8,239,079 | 145,223 | Oct 30, 2013, 05:59 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 28, 2013 | Sale | $123.89 | 1,000 | 123,890 | 104,186 | Oct 30, 2013, 05:59 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Sep 24, 2013 | Sale | $112.54 | 304 | 34,212 | 105,186 | Sep 26, 2013, 04:59 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Sep 13, 2013 | Sale | $114.37 | 1,000 | 114,370 | 105,490 | Sep 17, 2013, 06:09 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Aug 05, 2013 | Sale | $116.87 | 852 | 99,573 | 106,490 | Aug 07, 2013, 05:27 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Aug 02, 2013 | Sale | $73.49 | 28,250 | 2,075,981 | 121,467 | Aug 02, 2013, 05:02 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Jul 30, 2013 | Sale | $110.86 | 1,120 | 124,163 | 107,342 | Aug 01, 2013, 05:04 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Jul 12, 2013 | Option Exercise | $70.46 | 36,000 | 2,536,570 | 126,462 | Jul 16, 2013, 04:47 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Global Ops. Officer | Jul 01, 2013 | Sale | $67.05 | 88,250 | 5,917,385 | 152,587 | Jul 03, 2013, 04:49 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Global Ops. Officer | Apr 29, 2013 | Sale | $66.35 | 72,998 | 4,843,078 | 144,961 | May 01, 2013, 06:29 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Head of R&D | Mar 08, 2013 | Option Exercise | $55.44 | 40,000 | 2,217,512 | 128,462 | Mar 12, 2013, 04:39 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Head of R&D | Feb 04, 2013 | Sale | $95.68 | 2,572 | 246,081 | 81,977 | Feb 06, 2013, 06:07 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Head of R&D | Jan 28, 2013 | Sale | $94.50 | 715 | 67,568 | 85,264 | Jan 30, 2013, 05:23 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Head of R&D | Jan 29, 2013 | Sale | $94.32 | 767 | 72,343 | 84,497 | Jan 30, 2013, 05:23 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 31, 2012 | Sale | $105.01 | 1,015 | 106,585 | 85,979 | Jul 31, 2012, 04:44 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 27, 2012 | Option Exercise | $64.27 | 200,668 | 12,896,429 | 187,662 | Jul 31, 2012, 04:44 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 09, 2012 | Sale | $59.21 | 100,000 | 5,920,772 | 137,662 | Jul 11, 2012, 04:26 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jun 06, 2012 | Sale | $53.82 | 100,000 | 5,382,500 | 137,662 | Jun 08, 2012, 03:34 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Feb 17, 2012 | Sale | $49.23 | 110,520 | 5,440,986 | 142,922 | Feb 22, 2012, 05:23 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jan 27, 2012 | Sale | $74.41 | 663 | 49,334 | 77,626 | Jan 30, 2012, 05:03 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jan 30, 2012 | Sale | $74.51 | 3,004 | 223,828 | 74,662 | Jan 30, 2012, 05:03 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jan 10, 2012 | Sale | $75.00 | 562 | 42,150 | 78,289 | Jan 11, 2012, 05:26 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Oct 24, 2011 | Option Exercise | $40.61 | 105,480 | 4,283,055 | 131,591 | Oct 25, 2011, 04:00 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 26, 2011 | Sale | $33.82 | 56,000 | 1,893,640 | 106,270 | Jul 27, 2011, 04:52 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 27, 2011 | Sale | $57.27 | 669 | 38,314 | 77,601 | Jul 27, 2011, 04:52 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 11, 2011 | Sale | $50.00 | 502 | 25,100 | 78,270 | Jul 12, 2011, 04:09 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Mar 02, 2011 | Option Exercise | $59.85 | 10,000 | 598,450 | 44,637 | Mar 04, 2011, 03:50 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research and Development | Feb 18, 2011 | Option Exercise | $57.50 | 20,000 | 1,150,000 | 49,637 | Feb 23, 2011, 04:53 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Jan 27, 2011 | Sale | $84.70 | 1,330 | 112,651 | 32,917 | Jan 28, 2011, 04:29 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Jan 18, 2011 | Sale | $49.97 | 68,346 | 3,415,280 | 68,247 | Jan 18, 2011, 05:03 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Jan 10, 2011 | Sale | $81.27 | 280 | 22,756 | 34,593 | Jan 12, 2011, 01:02 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Nov 03, 2010 | Option Exercise | $40.25 | 20,000 | 805,000 | 44,873 | Nov 05, 2010, 04:30 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Sep 13, 2010 | Sale | $35.98 | 24,832 | 893,357 | 42,289 | Sep 13, 2010, 04:36 PM |